Phase 3, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of PF-07055480 (Recombinant AAV2/6 Human Factor VIII Gene Therapy) in Adult Male Participants with Moderately Severe to Severe Hemophilia A (FVIII:C<=1%) (NCT04370054)
AFFINE
This trial is No longer recruiting
Registration number NCT04370054
Program & service
This trial is being run with the Cancer service, and as part of the Haemophilia program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Professor Huyen Tran
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR